![]() |
市場調査レポート
商品コード
1541303
獣医用リファレンスラボラトリーの市場レポート:技術、用途、動物タイプ、地域別、2024~2032年Veterinary Reference Laboratory Market Report by Technology, Application, Animal Type, and Region 2024-2032 |
||||||
カスタマイズ可能
|
獣医用リファレンスラボラトリーの市場レポート:技術、用途、動物タイプ、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2~3営業日
|
世界の獣医用リファレンスラボラトリーの市場規模は2023年に42億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに102億米ドルに達し、2024~2032年の間に10.2%の成長率(CAGR)を示すと予測しています。人獣共通感染症の増加、診断技術の急速な進歩、ペット飼育と動物の健康意識の高まり、厳格な規制の実施、動物医療施設とサービスの拡大により、市場は活況を呈しています。
市場の成長と規模市場は安定した成長を遂げており、その原動力となっているのは、動物用健康診断薬に対する需要の増加、ペット飼育数の増加、畜産需要の拡大、高度な診断ソリューションに対するニーズなどです。
主要市場促進要因:市場成長に影響を与える主要促進要因としては、人獣共通感染症の流行増加、動物用診断薬の進歩、ペットの飼い主や農業従事者における動物の健康に対する意識の高まりなどが挙げられます。
主要市場動向:主要市場動向には、獣医療セグメントにおける分子診断学とPOCT(Point-of-Care Testing)の導入に向けた継続的なシフトが含まれます。さらに、試験室プロセスにおけるデジタル技術と自動化の統合が市場の成長を後押ししています。
地理的動向:北米は、高度な獣医医療インフラと高いペット飼育率により市場をリードしています。その他の中東・アフリカも、動物の健康に対する意識の高まりと動物医療サービスの拡大により、著しい成長を示しています。
競合情勢:市場は、研究開発(R&D)や戦略的提携に積極的に投資し、サービスの提供や世界展開を強化している主要企業の関与によって特徴付けられています。さらに、各社は革新的な診断方法の開発や獣医療におけるデジタルソリューションの拡大に注力しています。
課題と機会:同市場は、先進的な診断法の高コストや、地域によっては熟練した獣医専門家の不足など、さまざまな課題に直面しています。しかし、費用対効果の高いソリューションやトレーニングプログラムへの投資が増加しており、市場成長の新たな機会が生まれつつあります。
人獣共通感染症の増加
動物からヒトへの感染症を媒介する人畜共通感染症の流行増加は、市場成長を促進する主要要因の1つです。これに伴い、人と動物の相互作用の増加、生息地の侵食、人と動物の世界の移動により、疾病を検出し管理するための高度な診断方法の必要性が高まっており、市場の成長を後押ししています。人獣共通感染症の正確な診断とモニタリングには、高度な技術と専門的な知識を備えた動物用標準試験室が不可欠です。これに加えて、公衆衛生に対する関心の高まりと動物福祉を確保する必要性から、動物用標準試験室への依存度が高まっており、市場成長の原動力になると予想されます。
動物用診断における急速な進歩
分子診断学、免疫診断学、高度画像診断技術の開発など、動物用診断技術や診断ツールの急速な進歩は、市場成長を大きく後押しする主要因です。これらの技術により、より正確で迅速かつ包括的な診断評価が可能になり、動物の疾病の早期発見と効果的な管理が可能になります。さらに、様々な動物の健康問題の治療とコントロールのために、信頼性の高いタイムリーな結果を提供するのに役立つ最先端の技術を動物用標準試験室に取り入れることは、市場の成長を促進すると予想されます。さらに、動物用診断薬の研究開発(R&D)が進んでおり、新規かつ効率的な試験法の導入につながっていることも、市場に有利な成長機会をもたらしています。
ペット飼育の増加と動物の健康意識
世界中でペットの飼育数が増加しており、診断など様々なサービスを提供する獣医用リファレンスラボラトリーに対する需要を牽引していることが、市場成長に明るい展望をもたらしています。さらに、ペットの数の増加と、動物の健康とウェルネスに対する飼い主の意識の高まりが、成長を促す要因となっています。これに伴い、定期的な健康診断や診断テストを含む、ペットのための質の高い医療に対する飼い主の投資が増加しており、市場成長に弾みをつけています。これとともに、定期的な血液試験や診断手順など幅広いサービスを提供する動物用標準試験機関の利用が高まっていることも、市場成長に寄与しています。
規制強化と動物の健康モニタリング
動物の健康と安全を確保するために、世界中の政府や規制機関が厳しい規制指令や動物の健康モニタリングプログラムを実施していることが、市場の成長にプラスの影響を与えています。これに伴い、食品生産における家畜やその他の動物の定期的な健康モニタリングと診断試験を義務付ける規制の採用が市場成長を促進しています。これとともに、正確で信頼性の高い試験サービスを提供するための動物用標準試験機関の採用が増加していることも、市場の成長を支えています。さらに、食品の安全性と品質への注目の高まりが、食品生産動物の定期的な健康モニタリングの必要性を促し、市場の成長を刺激しています。これに加えて、動物の疾病の予防と制御を目的とした動物の健康モニタリングプログラムの実施が、市場の成長を促進しています。
動物用医療施設とサービスの拡大
世界中で動物用医療施設が拡大し、動物用標準試験室が提供する専門的な診断サービスの必要性が高まっていることが、市場成長を促進する要因となっています。これとともに、家畜人口に対する獣医療的サービスに対する需要の高まりにより、地方でのサービス拡大が広がっていることも、市場成長に大きな後押しとなっています。これに加えて、高度な診断ツールを備えた動物病院やクリニックの設立が増加し、専門的な試験や分析のための標準試験機関への依存度が高まっていることも、市場成長に弾みをつけています。これとは別に、獣医専門家の数の増加と獣医療における継続的な進歩が、獣医用標準試験室に対する需要の急増に寄与しており、市場成長を刺激しています。
The global veterinary reference laboratory market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 10.2% during 2024-2032. The market is thriving due to the increasing prevalence of zoonotic diseases, rapid advancements in diagnostic technologies, rising pet ownership and animal health awareness, the implementation of stringent regulatory mandates, and the expansion of veterinary healthcare facilities and services.
Market Growth and Size: The market is witnessing stable growth, driven by increasing demand for animal health diagnostics, rising pet ownership, growing demand for livestock production, and the need for advanced diagnostic solutions.
Major Market Drivers: Key drivers influencing the market growth include the rising prevalence of zoonotic diseases, advancements in veterinary diagnostics, and the heightened awareness about animal health among pet owners and farmers.
Key Market Trends: The key market trends involve the ongoing shift towards the adoption of molecular diagnostics and point-of-care testing (POCT) in the veterinary field. Additionally, the integration of digital technologies and automation in laboratory processes is bolstering the market growth.
Geographical Trends: North America leads the market due to its advanced veterinary healthcare infrastructure and high pet ownership rates. Other regions are also showing significant growth, fueled by the increasing awareness about animal health and expanding veterinary healthcare services.
Competitive Landscape: The market is characterized by the active involvement of key players who are investing in research and development (R&D) and strategic collaborations to enhance their service offerings and global reach. Furthermore, companies are focusing on developing innovative diagnostic methods and expanding digital solutions in veterinary care.
Challenges and Opportunities: The market faces various challenges, such as the high cost of advanced diagnostics and the lack of skilled veterinary professionals in some regions. However, the increasing investment in cost-effective solutions and training programs, is creating new opportunities for the market growth.
Increasing prevalence of zoonotic diseases
The rising prevalence of zoonotic diseases that transmit infections from animals to humans is one of the major factors propelling the market growth. In line with this, the increasing interaction between humans and animals, habitat encroachment, and the global movement of people and animals, necessitating the need for advanced diagnostic methods to detect and manage diseases, is boosting the market growth. Veterinary reference laboratories are equipped with advanced technologies and specialized expertise, making them essential for the accurate diagnosis and monitoring of zoonotic diseases. In addition to this, the growing reliance on veterinary reference laboratories due to the escalating concern over public health, coupled with the need to ensure animal welfare, is anticipated to drive the market growth.
Rapid advancements in veterinary diagnostics
The rapid advancements in veterinary diagnostic technologies and diagnostic tools, such as the development of molecular diagnostics, immunodiagnostics, and advanced imaging technologies, are major factors providing a considerable boost to the market growth. They allow for more precise, rapid, and comprehensive diagnostic evaluations, enabling early detection and effective management of animal diseases. Moreover, the incorporation of cutting-edge technologies in veterinary reference laboratories that help in providing reliable and timely results for the treatment and control of various animal health issues, is anticipated to drive the market growth. Additionally, the ongoing research and development (R&D) in veterinary diagnostics, leading to the introduction of novel and more efficient testing methods, is offering lucrative growth opportunities for the market.
Growing pet ownership and animal health awareness
The increasing pet ownership across the globe, driving the demand for veterinary reference laboratories for various services like diagnostics, is creating a positive outlook for the market growth. Moreover, the rising number of pets, coupled with the growing awareness among pet owners about animal health and wellness, is acting as a growth-inducing factor. In line with this the increasing investment by pet owners in quality healthcare for pets, which includes regular health check-ups and diagnostic tests, is providing an impetus to the market growth. Along with this, the heightened utilization of veterinary reference laboratories, as they offer a wide range of services, such as routine blood tests and diagnostic procedures, is contributing to the market growth.
Implementation of regulatory mandates and animal health monitoring
The implementation of stringent regulatory mandates and animal health monitoring programs by governments and regulatory bodies across the globe to ensure animal health and safety is positively impacting the market growth. In line with this, the introduction of regulations requiring regular health monitoring and diagnostic testing of livestock and other animals in food production is propelling the market growth. Along with this, the rising adoption of veterinary reference laboratories for providing accurate and reliable testing services is supporting the market growth. Additionally, the burgeoning focus on food safety and quality, prompting the need for regular health monitoring of food-producing animals, is stimulating the market growth. In addition to this, the implementation of animal health monitoring programs aimed at preventing and controlling animal diseases is driving the market growth.
Expansion of veterinary healthcare facilities and services
The expansion of veterinary healthcare facilities across the globe, prompting the need for specialized diagnostic services offered by veterinary reference laboratories, is acting as a growth-inducing factor. Along with this, the widespread service expansion in rural regions due to the rising demand for veterinary services for the livestock population is providing a considerable boost to the market growth. In addition to this, the growing establishment of veterinary clinics and hospitals equipped with advanced diagnostic tools, fostering the reliance on reference laboratories for specialized tests and analyses, is providing an impetus to the market growth. Apart from this, the rising number of veterinary professionals and the continuous advancements in veterinary medicine, contributing to the burgeoning demand for veterinary reference laboratories, are stimulating the market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on technology, application, and animal type.
Clinical Chemistry
Hematology
Immunodiagnostics
ELISA
Lateral Flow Rapid Tests
Others
Molecular Diagnostics
PCR
Microassays
Others
Others
Clinical chemistry accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the technology. This includes clinical chemistry, hematology, immunodiagnostics (ELISA, lateral flow rapid tests, and others), molecular diagnostics (PCR, microassays, and others), and others. According to the report, clinical chemistry represented the largest segment.
Clinical chemistry represents the largest share of the market, as it encompasses a wide array of tests for assessing organ function, metabolic state, and electrolyte balance, making it crucial for routine health check-ups and disease diagnosis. Moreover, the extensive application of clinical chemistry in diagnosing various conditions, including liver and kidney diseases, diabetes, and hormonal imbalances, is providing a thrust to the market growth. Additionally, the development of automated analyzers and reagents to enhance the efficiency and accuracy of clinical chemistry tests is boosting the market growth.
Hematology emphasizes the analysis of blood components, which include platelets, red blood cells (RBCs), and white blood cells (WBCs). It aids in diagnosing a wide range of blood disorders, including anemia, infections, and clotting problems. Hematology tests are essential for routine health screenings and are increasingly used in veterinary clinics for immediate diagnosis, aiding in timely treatment decisions for various blood-related conditions in animals.
Immunodiagnostics helps in detecting specific antigens or antibodies and provides valuable insights into the immune status of animals. It includes tests, such as enzyme-linked immunosorbent assays (ELISA) and rapid immunoassay for diagnosing infectious diseases, allergies, and immune disorders. Moreover, the growing prevalence of infectious diseases in animals and the need for efficient disease management strategies are favoring the market growth.
Molecular diagnostics is characterized by its precision and accuracy in detecting the genetic material of pathogens. It includes sophisticated techniques like polymerase chain reaction (PCR) and next-generation sequencing (NGS) for identifying genetic diseases, mutations, and infectious agents at a molecular level. Additionally, the rising adoption of molecular diagnostics due to its ability to provide rapid and definitive results, especially in the identification of novel pathogens and drug-resistant strains, is boosting the market growth.
Clinical Pathology
Toxicology
Productivity Testing
Others
Clinical pathology holds the largest share in the industry
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes clinical pathology, toxicology, productivity testing, and others. According to the report, clinical pathology accounted for the largest market share.
Clinical pathology dominates the market, as it helps in the diagnosis and management of animal diseases. It encompasses a broad spectrum of tests, including blood tests, urinalysis, histopathology, and cytology, essential for diagnosing a wide range of conditions like infections and cancer. Moreover, the rising prominence of clinical pathology due to its comprehensive approach to evaluating animal health, offering vital insights into the physiological and pathological states of different organ systems, is creating a positive outlook for the market growth. Additionally, rapid advancements in diagnostic techniques and the growing demand for accurate, timely diagnosis in veterinary medicine are boosting the market growth.
Toxicology focuses on detecting and analyzing toxic substances and their effects on animals. It is crucial to identify exposure to toxins, including pesticides, heavy metals, and other environmental contaminants that can adversely affect animal health. Toxicology testing is also essential for monitoring and preventing exposure to harmful substances in domestic and wild animals.
Productivity testing includes various tests aimed at evaluating the health and productivity of livestock animals for efficient farm management. They assess reproductive health, milk quality, and nutritional status, directly impacting the profitability of livestock businesses. Moreover, the increasing demand for productivity testing, fueled by the growing need for sustainable and efficient livestock production, is enhancing the market growth.
Livestock Animals
Companion Animals
Livestock animals represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the animal type. This includes livestock animals and companion animals. According to the report, livestock animals represented the largest segment.
Livestock animals dominate the market, as veterinary reference laboratories include diagnostic services for a variety of animals, including cattle, swine, poultry, sheep, and goats, which are essential for the production of meat, milk, and eggs. Moreover, the growing need for maintaining the health and productivity of livestock, which directly impacts food security and economic stability is boosting the market growth. In addition to this, the increasing adoption of regular health monitoring, disease testing, and genetic screening in livestock for early disease detection, effective treatment, and prevention of outbreaks, thereby ensuring the safety and quality of animal-derived products, is catalyzing the market growth.
The increasing utilization of veterinary reference laboratories for companion animals due to the increasing pet ownership and the humanization of pets is favoring the market growth. It includes diagnostic services for pets, such as dogs, cats, and horses. Moreover, the rising pet healthcare expenditure and the growing awareness among pet owners about preventive healthcare are contributing to the market growth.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest veterinary reference laboratory market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America leads the veterinary reference laboratory market due to its advanced veterinary healthcare infrastructure, high pet ownership rates, and implementation of stringent animal health regulations. Moreover, the growing emphasis on pet health and wellness, coupled with substantial spending on animal healthcare, is boosting the market growth. In addition to this, the presence of major veterinary reference laboratories, along with the adoption of cutting-edge diagnostic technologies, is fueling the market growth. Additionally, the heightened focus on livestock health for food safety and quality, propelling the demand for various veterinary diagnostic services in North America, is fostering the market growth.
Europe holds a significant share of the veterinary reference laboratory market, driven by its well-established animal healthcare system and high standards for animal welfare. Moreover, the presence of several leading veterinary diagnostic companies and research institutions, which contribute to the development and adoption of advanced diagnostic techniques, is enhancing the market growth.
The Asia Pacific region is a rapidly emerging segment in the veterinary reference laboratory market, attributed to the increasing awareness about animal health, rising pet ownership, and growing livestock sector in several countries. Moreover, the development of veterinary healthcare infrastructure and services, along with increased government initiatives for animal health and welfare, is expanding the market growth.
Latin America's veterinary reference laboratory market is growing, driven by the increasing focus on livestock health and productivity. Moreover, the region's popularity as a large livestock population and the increasing investment in veterinary healthcare to improve the quality and safety of their animal-derived products are major factors fueling the market growth.
The veterinary reference laboratory market in the Middle East and Africa is growing due to the heightened demand for improved livestock management and pet care. Moreover, the region's focus on enhancing its veterinary healthcare infrastructure to address challenges, such as infectious diseases, and to ensure food security through healthy livestock is providing a thrust to the market growth.
The major players in the market are engaging in a variety of strategic activities to strengthen their position and expand their market share. They are heavily investing in research and development (R&D) to introduce innovative diagnostic tests and technologies that offer more accurate, faster, and comprehensive results. Moreover, some players are focusing on the development of molecular diagnostics and point-of-care (POC) testing devices, which are revolutionizing veterinary diagnostics by providing precise results in a shorter time frame. Besides this, they are actively pursuing mergers, acquisitions, and partnerships with other companies and research institutions to broaden their service offerings and reach.
Boehringer Ingelheim GmbH
IDEXX Laboratories Inc.
Neogen Corporation
Phoenix Central Laboratory for Veterinarians Inc. (Zoetis Inc.)
ProtaTek International Inc. (Pharmgate LLC)
Royal GD
Texas A&M Veterinary Medical Diagnostic Laboratory
VCA Inc. (Mars Incorporated)
Virbac Animal Health India Private Limited
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
In June 2022, IDEXX Laboratories Inc. announced the launch of its new reference laboratory tests and services that will help veterinarians gain insights during wellness screenings, develop treatment plans for cats with chronic kidney disease, and access fast, definitive answers for the most critical cases.
In December 2021, Neogen Corporation acquired Genetics Veterinary Sciences, Inc. (US) to increase the genetic testing portfolio for companion animals.
In November 2023, Boehringer Ingelheim received marketing authorization from the European Commission for SENVELGO, the first once-daily liquid oral solution for the reduction of hyperglycemia in cats with non-insulin-dependent diabetes mellitus.